Pluton Biosciences
PrivateLast Round
Series A
May 24, 2023
Total Funding Raised
$23.11M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Pluton Biosciences operates in Healthcare & Life Sciences and is based in Saint Louis, Michigan. Its latest recorded funding round was a Series A round in May 2023.
Pluton Biosciences is a biotechnology company that leverages its Micromining platform to discover novel microbes for sustainable solutions in agriculture, such as crop protection and carbon sequestration.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Carbon Capture, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pluton Biosciences Comparables
Compare Pluton Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Concerto Biosciences | 86% | |
| FA Bio | 85% | |
| BioConsortia, Inc. | 82% |
For institutional investors. Book with your work email.
Pluton Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 24, 2023 | ||||
| Seed | Oct 5, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Pluton Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Better Ventures | Seed |
| iSelect Fund | Series A |
| RA Capital Management | Series A |
| Fall Line Capital | Series A, Seed |
| Grantham Foundation for the Protection of the Environment | Series A |
| Radicle Growth | Series A |
| The Grantham Foundation for the Protection of the Environment | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 150% MoM.
- Aug 1, 2026
Open roles increased to 7, representing 26% of headcount.
For institutional investors. Book with your work email.
Pluton Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Pluton Biosciences's valuation, stock price, and market status.
Is Pluton Biosciences a public or private company?
Pluton Biosciences is a private company.
What is the current stock price of Pluton Biosciences?
Pluton Biosciences is a private company, so its shares have no public market price. Caplight tracks Pluton Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pluton Biosciences worth (valuation)?
Valuation information for Pluton Biosciences is not publicly available.
Can I buy Pluton Biosciences stock?
Pluton Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pluton Biosciences's last funding round?
Pluton Biosciences's most recent funding round was Series A on May 24, 2023.
Who are the main investors in Pluton Biosciences?
Key investors in Pluton Biosciences include Better Ventures, RA Capital Management, Illumina Ventures.
Will Pluton Biosciences IPO soon?
No public IPO plans have been announced for Pluton Biosciences.
How can I track Pluton Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Pluton Biosciences's shares on secondary markets.